In May 2026, the Dutch Health and Youth Care Inspectorate (Inspectie Gezondheidszorg en Jeugd, IGJ) conducted a rigorous on-site EU GMP audit of Hebei Daoen Pharmaceutical, a strategic partner of Pharmacare (Nanjing).
The audit was triggered by an in-house developed complex injectable project of Hebei Daoen Pharmaceutical, whose registration application was led by Pharmacare. Acting as the European MAH and exclusive agent for Hebei Daoen Pharmaceutical, Pharmacare participated in the whole process. We provided full-chain supporting services including GMP gap analysis, corrective action recommendations, mock audit organization, official audit coordination and on-site inquiry support.
Leveraging its seven-in-one one-stop empowerment platform, Pharmacare (Nanjing) adheres to the core values of “Integrity, Perseverance, Collaboration, Innovation, Dedication and Win-Win Results”. Focusing on the pharmaceutical global expansion track, we keep undertaking difficult yet worthwhile tasks, continuously empower upstream and downstream partners, and contribute to the internationalization of China’s pharmaceutical industry.
